Next-generation sequencing (NGS) is often used in liquid biopsy research to detect a wide range of genes or whole genome sequencing. Targeted sequencing, while limited to detecting a specific set of mutations, offers higher sensitivity compared to whole genome sequencing. This makes tools like the Trusight Myeloid Sequencing Panel highly effective for clinical research studies.
In this Tech Note, see how the NEAT Liquid Biopsy Kit shows compatibility with the Illumina Trusight Myeloid Sequencing Panel, demonstrating its potential as an
effective tool for identifying specific mutations in liquid biopsies through NGS.
TECHNICAL NOTE SKU 77XXX
Commentaires